BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
企業コードBLFS
会社名BioLife Solutions Inc
上場日Nov 22, 1989
最高経営責任者「CEO」Mr. Roderick De Greef
従業員数159
証券種類Ordinary Share
決算期末Nov 22
本社所在地Suite 310
都市BOTHELL
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号98021
電話番号14254011400
ウェブサイトhttps://www.biolifesolutions.com/
企業コードBLFS
上場日Nov 22, 1989
最高経営責任者「CEO」Mr. Roderick De Greef
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし